Biopsy Devices Market by Product, Technique, Application, End User

List of Tables

The Biopsy Devices Market was valued at USD 9.47 billion in 2023, expected to reach USD 10.46 billion in 2024, and is projected to grow at a CAGR of 10.82%, to USD 19.46 billion by 2030.

Biopsy devices are crucial diagnostic tools employed to extract cells or tissue samples for examination, typically to detect cancer, infections, or inflammatory conditions. The necessity for these devices stems from their vital role in facilitating early diagnosis and enabling precision treatment, thereby enhancing patient outcomes. Applications of biopsy devices span across oncology, gynecology, urology, and more. They are increasingly leveraged in outpatient settings due to the advent of minimally invasive techniques. End-use sectors primarily include hospitals, diagnostic centers, and research institutes. Market growth is significantly influenced by factors such as the rising prevalence of cancer and chronic diseases, technological advancements in biopsy techniques, and increasing demand for minimally invasive procedures. Emerging markets and increasing healthcare expenditure further present ample opportunities, particularly in developing regions where healthcare infrastructure is expanding. Strategic recommendations include investing in the development of more portable and user-friendly devices, focusing on integration with digital solutions for better data analytics and patient monitoring, and fostering collaborations for product innovations. Conversely, high costs associated with advanced biopsy devices and stringent regulatory requirements pose significant limitations, while challenges such as the lack of skilled professionals and procedure-associated risks affect market penetration. Key areas for innovation include the development of robotics-assisted biopsy devices, enhanced imaging technologies to improve precision, and wearable biopsy tools to facilitate at-home diagnostics. Additionally, research can focus on automation in biopsy collection and sample analysis for enhanced efficiency and reduced human errors. Understanding these dynamics reveals that the biopsy devices market is transitioning towards a more technology-driven ecosystem, where increased investment in R&D and a focus on user-centric solutions can catalyze market expansion and offer substantial business growth opportunities.

KEY MARKET STATISTICS
Base Year [2023]	USD 9.47 billion
Estimated Year [2024]	USD 10.46 billion
Forecast Year [2030]	USD 19.46 billion
CAGR (%)	10.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopsy Devices Market

The Biopsy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Growing incidences of cancer and gastrointestinal diseases
- Rise in adoption of minimally-invasive techniques
- Increasing awareness of the importance of early detection and screening of diseases
Market Restraints
- High cost associated with the production of biopsy devices
Market Opportunities
- Continuous technological advancements in biopsy devices
- Growing inclination towards liquid biopsy devices
Market Challenges
- Problems associated with stringent regulations by health authorities

Porter's Five Forces: A Strategic Tool for Navigating the Biopsy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopsy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopsy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopsy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopsy Devices Market

A detailed market share analysis in the Biopsy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopsy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopsy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Biopsy Devices Market, highlighting leading vendors and their innovative profiles. These include Integra LifeSciences Holdings Corporation, F. Hoffmann-La Roche Ltd., Stryker Corporation, CONMED Corporation, Danaher Corporation, Innovia Medical, Remington Medical, Spectra Medical Devices, LLC, PAJUNK GmbH Medizintechnologie, Cardinal Health, Inc., Argon Medical Devices, Inc., Medtronic PLC, B. Braun SE, Advin Health Care, Fujifilm Holdings Corporation, MediTech Devices Pvt Ltd., Suretech Medical Inc., Olympus Corporation, Trajan Scientific and Medical Pty Ltd., Merit Medical Systems, Inc., TSK Laboratory, Axlab Limited, Ferrosan Medical Devices A/S, UVision360, INRAD, Inc., Volkmann MedizinTechnik GmbH, JEB Technologies Limited, Guardant Health, Inc., IZI Medical Products, LLC by Halma PLC, Zamar Care, Mermaid Medical, Limaca-Medical, Cook Group Incorporated, Hologic, Inc., Becton, Dickinson and Company, weLLgo Medical Products GmbH, Boston Scientific Corporation, and TransMed7, LLC.

Market Segmentation & Coverage

This research report categorizes the Biopsy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Product, market is studied across Biopsy Forceps, Localization Wires, Needle-Based Biopsy Instruments, and Procedure Trays. The Needle-Based Biopsy Instruments is further studied across Aspiration Needles, Core Biopsy Devices, and Vacuum-Assisted Biopsy Devices.
Based on Technique, market is studied across Image Guided Biopsy and Non-Image Guided Biopsy. The Image Guided Biopsy is further studied across MRI-Guided Biopsy, Stereotactic-Guided Biopsy, and Ultrasound-Guided Biopsy.
Based on Application, market is studied across Bone Marrow Biopsy, Breast Biopsy, Kidney Biopsy, Lung Biopsy, and Prostate Biopsy.
Based on End User, market is studied across Academic & Research Institutes, Diagnostic & Imaging Centers, and Hospitals.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-4103B31E073F

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing incidences of cancer and gastrointestinal diseases
  - 5.1.1.2. Rise in adoption of minimally-invasive techniques
  - 5.1.1.3. Increasing awareness of the importance of early detection and screening of diseases
- 5.1.2. Restraints
  - 5.1.2.1. High cost associated with the production of biopsy devices
- 5.1.3. Opportunities
  - 5.1.3.1. Continuous technological advancements in biopsy devices
  - 5.1.3.2. Growing inclination towards liquid biopsy devices
- 5.1.4. Challenges
  - 5.1.4.1. Problems associated with stringent regulations by health authorities
5.2. Market Segmentation Analysis
- 5.2.1. Product: Growing preference for needle-based biopsy instruments as it provide minimal risk of complications
- 5.2.2. Technique: Significant role of MRI-guided biopsy in biopsy device for high diagnosis accuracy
- 5.2.3. Application: Growing need for breast and prostate biopsy devices due to increasing instances of cancer in both areas
- 5.2.4. End User: Rising utilization of biopsy devices that promote lesser recovery time in the hospitals
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Biopsy Devices Market, by Product

6.1. Introduction
6.2. Biopsy Forceps
6.3. Localization Wires
6.4. Needle-Based Biopsy Instruments
- 6.4.1. Aspiration Needles
- 6.4.2. Core Biopsy Devices
- 6.4.3. Vacuum-Assisted Biopsy Devices
6.5. Procedure Trays

7. Biopsy Devices Market, by Technique

7.1. Introduction
7.2. Image Guided Biopsy
- 7.2.1. MRI-Guided Biopsy
- 7.2.2. Stereotactic-Guided Biopsy
- 7.2.3. Ultrasound-Guided Biopsy
7.3. Non-Image Guided Biopsy

8. Biopsy Devices Market, by Application

8.1. Introduction
8.2. Bone Marrow Biopsy
8.3. Breast Biopsy
8.4. Kidney Biopsy
8.5. Lung Biopsy
8.6. Prostate Biopsy

9. Biopsy Devices Market, by End User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Diagnostic & Imaging Centers
9.4. Hospitals

10. Americas Biopsy Devices Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Biopsy Devices Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Biopsy Devices Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. LUMINELLE Announces China National Intellectual Property Administration's Decision to Grant Issuance of Patent for LUMINELLE Bx (Biopsy) System, Expanding Global Footprint
- 13.3.2. Limaca Medical Receives FDA 510(k) Clearance for its Breakthrough Precision GI Endoscopic Biopsy Device
- 13.3.3. Stryker Announces Commercial Launch of Q Guidance System with Cranial Guidance Software
- 13.3.4. Merit Medical Acquires AngioDynamics' Catheter Portfolio and Biopsy System
- 13.3.5. Argon's SuperCore Advantage Biopsy Instrument Launched in United States
- 13.3.6. Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
- 13.3.7. Innovia Medical Launches the Oral Rotating Biopsy Punch at BACO International 2023
- 13.3.8. Guardant360 CDx Gets FDA Approval as Companion Diagnostic for ORSERDU
- 13.3.9. TransMed7, LLC Announces First Clinical Use of SpeedBird Breast Biopsy Devices for Commercial Launch
- 13.3.10. Terumo India Partners with Argon Medical to Expand Portfolio

Companies Mentioned

1. Integra LifeSciences Holdings Corporation
2. F. Hoffmann-La Roche Ltd.
3. Stryker Corporation
4. CONMED Corporation
5. Danaher Corporation
6. Innovia Medical
7. Remington Medical
8. Spectra Medical Devices, LLC
9. PAJUNK GmbH Medizintechnologie
10. Cardinal Health, Inc.
11. Argon Medical Devices, Inc.
12. Medtronic PLC
13. B. Braun SE
14. Advin Health Care
15. Fujifilm Holdings Corporation
16. MediTech Devices Pvt Ltd.
17. Suretech Medical Inc.
18. Olympus Corporation
19. Trajan Scientific and Medical Pty Ltd.
20. Merit Medical Systems, Inc.
21. TSK Laboratory
22. Axlab Limited
23. Ferrosan Medical Devices A/S
24. UVision360
25. INRAD, Inc.
26. Volkmann MedizinTechnik GmbH
27. JEB Technologies Limited
28. Guardant Health, Inc.
29. IZI Medical Products, LLC by Halma PLC
30. Zamar Care
31. Mermaid Medical
32. Limaca-Medical
33. Cook Group Incorporated
34. Hologic, Inc.
35. Becton, Dickinson and Company
36. weLLgo Medical Products GmbH
37. Boston Scientific Corporation
38. TransMed7, LLC